Skip to main content

Gordon Brothers Supports Middle West Partners’ Acquisition of Paul Stuart with Strategic Financing

Financing both funded the acquisition and will allow for future financing to support further investments in the brand Boston, March 02, 2026 (GLOBE NEWSWIRE) — Gordon Brothers, the global asset experts, provided strategic private credit financing to support Middle West Partners’ (MWP) acquisition of Paul Stuart, a New York-based luxury brand famous for its suits, dress apparel, sportswear, footwear and accessories. The revolving line of credit both funded the acquisition and will provide working capital to support further investments in the brand. In addition, Carolyn D’Angelo, Senior Managing Director, Head of Brand Operations at Gordon Brothers will serve on the newly established Paul Stuart Advisory Board to provide ongoing support for brand growth and development, and the firm will be engaged for advisory service work. “We...

Continue reading

MyFitnessPal Acquires Cal AI, Expanding on its Position as the Leading Player in Digital Nutrition Tracking

The acquisition brings together two complementary nutrition brands, giving the company the ability to serve consumers across the full health and fitness spectrum NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) — MyFitnessPal, the No. 1 global nutrition and food tracking app, today announced its acquisition of Cal AI, a fast-growing, AI-powered nutrition app. The deal reflects MyFitnessPal’s continued investment in innovation as a category leader in digital nutrition, following the company’s acquisition of the meal planning app Intent last year and its integration with ChatGPT Health in January. MyFitnessPal and Cal AI serve distinct but complementary audiences united by a shared mission, helping people reach their health and fitness goals. With more than 20 years of science-backed education, one of the largest food databases in the world,...

Continue reading

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

MISSISSAUGA, Ontario, March 02, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) is pleased to announce that it has successfully closed the previously-announced acquisition of Oral Science Inc. (“Oral Science”), a privately-owned Canadian distributor of specialized healthcare products for dental hygiene and oral health based in Brossard, Quebec. Pursuant to the terms of a Share Purchase Agreement (“SPA”) dated February 8, 2026, BioSyent, through its wholly-owned subsidiary, completed the acquisition of Oral Science from the shareholders of Oral Science (the “Sellers”) in an arm’s length transaction. The aggregate purchase price was $25.5 million, satisfied by: (i) a cash payment of $22.5 million to the Sellers of which $0.2 million will be satisfied with the grant of 12,666 Restricted Share Units (“RSUs”)...

Continue reading

Colliers acquires Rome’s leading residential asset advisor

Enhances capabilities in development and urban regeneration projectsColliers acquires Progedil, Rome’s leading residential asset advisorColliers acquires Progedil, expanding Colliers’ ability to advise on large-scale urban regeneration and new-build development projects.ROME, March 02, 2026 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company Colliers announces the acquisition of Progedil, expanding Colliers’ ability to advise on large-scale urban regeneration and new-build development projects in one of Italy’s most dynamic residential markets. As part of the transaction, Progedil’s senior leadership team has retained significant equity in the business and will continue to lead the day-to-day operations.  Progedil provides full-service project marketing for residential...

Continue reading

Bitcoin Depot Expands Product Portfolio with Acquisition of Social Betting Platform, Kutt

Company Enters Peer-to-Peer Social Betting Market as Part of Broader Product Diversification Strategy ATLANTA, March 02, 2026 (GLOBE NEWSWIRE) — Bitcoin Depot (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced that it has acquired Kutt, a peer-to-peer (“P2P”) social betting platform that enables users to wager directly against each other on both private and publicly verifiable events. The acquisition marks Bitcoin Depot’s first entry into the P2P social betting market and reflects the Company’s broader strategy to diversify its product offerings beyond its core Bitcoin ATM business. Kutt’s platform is positioned within one of the fastest-growing segments of consumer fintech, as Americans wagered over $165 billion through U.S. sportsbooks in 2025, reflecting the continued expansion...

Continue reading

Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline

Acquisition will create a U.S.- and China-based fully integrated biopharmaceutical company with revenue-producing commercial assets and a robust pipeline of degraders, targeting inflammatory diseases and cancers. Access to degrader-antibody conjugates (DACs) platform technology for future discovery engine. Strengthened leadership team designed to support future global growth. Transaction is anticipated to close early in the second quarter of 2026. An updated corporate presentation has been posted to the Gyre and Cullgen websites.SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) — Gyre Therapeutics, Inc. (Gyre or the Company) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases, today announced its agreement to acquire...

Continue reading

Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement

TORONTO, March 02, 2026 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Inc. (“Xanadu”), a global leader in photonic quantum computing, and Crane Harbor Acquisition Corp. (Nasdaq: CHAC) (“Crane Harbor”), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (the “SEC”) has declared effective the companies’ joint registration statement on Form F-4 in connection with their previously announced proposed business combination. This marks a significant milestone in the transaction process and moves Xanadu substantially closer to becoming a publicly traded company. The business combination is expected to close in the first quarter of 2026, subject to the satisfaction of customary closing conditions, including the approval by Crane Harbor and Xanadu shareholders and the listing...

Continue reading

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

HEMANGEOL® is the only FDA-approved treatment for infantile hemangioma HEMANGEOL will be commercialized by Eton beginning May 1st HEMANGEOL will be distributed through the company’s Eton Cares™ patient support program, which includes a $0 co-pay initiative, to broaden patient access.DEER PARK, Ill., March 02, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced it has in-licensed U.S. commercialization rights to HEMANGEOL® oral solution from Pierre Fabre Medicament Sas (“Pierre Fabre”). HEMANGEOL is an Orphan Drug indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. “As the only treatment for infantile hemangiomas that...

Continue reading

HBT Financial, Inc. Completes Merger with CNB Bank Shares, Inc.

BLOOMINGTON, Ill., March 02, 2026 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding company for Heartland Bank and Trust Company (“Heartland Bank”), today announced that it has completed its merger with CNB Bank Shares, Inc. (“CNB”), the holding company for CNB Bank & Trust, N.A. (“CNB Bank”). At the effective time of the Merger, CNB merged with a wholly-owned subsidiary of HBT, with CNB surviving as a wholly-owned subsidiary of HBT. Immediately thereafter, CNB merged (the “Merger”) with and into HBT Financial, with HBT Financial surviving the Merger. In addition, following the Merger, CNB Bank, CNB’s wholly-owned bank subsidiary, merged with and into Heartland Bank, with Heartland Bank continuing as the surviving bank. As of December 31, 2025, CNB had $1.8 billion in...

Continue reading

CTO Realty Growth Announces Acquisition of Palms Crossing for $81.6 Million

WINTER PARK, Fla., March 02, 2026 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”), a leading owner and operator of high-quality, open-air shopping centers located in the higher growth Southeast and Southwest markets of the United States, today announced the acquisition of Palms Crossing (the “Property”), an open-air retail center consisting of 399,000 square feet for a purchase price of $81.6 million. Palms Crossing is currently 98% leased, anchored by Best Buy, Hobby Lobby, Burlington Coat Factory, Barnes & Noble and Nike. The Property is located on 47 acres in McAllen, Texas with a population of approximately 200,000 within a five-mile radius. Additionally, the Property features two pad sites situated on approximately six acres representing future development opportunities. With this acquisition,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.